These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6950174)

  • 21. [Halo Nevus (Morbus Sutton): model of an immunological tumor regression].
    Micksche M; Cerni C; Gebhart W; Kokoschka EM
    Osterr Z Onkol; 1975; 2(2-3):73-81. PubMed ID: 1243163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The factors of disease-free survival in patients with nodal metastases of cutaneous melanoma].
    Mikhnin AE; Barchuk AS
    Vopr Onkol; 2004; 50(4):426-9. PubMed ID: 15605765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth and regression of cutaneous melanomas in Sinclair miniature swine.
    Oxenhandler RW; Berkelhammer J; Smith GD; Hook RR
    Am J Pathol; 1982 Dec; 109(3):259-69. PubMed ID: 6758603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.
    Wagner SN; Schultewolter T; Wagner C; Briedigkeit L; Becker JC; Kwasnicka HM; Goos M
    Lab Invest; 1998 May; 78(5):541-50. PubMed ID: 9605179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
    Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
    Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term spontaneous regression of malignant melanoma with visceral metastases. Report of a case with immunologic profile.
    Bulkley GB; Cohen MH; Banks PM; Char DH; Ketcham AS
    Cancer; 1975 Aug; 36(2):485-94. PubMed ID: 1157014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
    Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
    J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimelanoma antibodies in swine with spontaneously regressing melanoma.
    Cui J; Chen D; Misfeldt ML; Swinfard RW; Bystryn JC
    Pigment Cell Res; 1995 Feb; 8(1):60-3. PubMed ID: 7792256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
    Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
    J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell distribution and adhesion receptor expression in metastatic melanoma.
    Weishaupt C; Munoz KN; Buzney E; Kupper TS; Fuhlbrigge RC
    Clin Cancer Res; 2007 May; 13(9):2549-56. PubMed ID: 17473183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.
    Ferradini L; Mackensen A; Genevée C; Bosq J; Duvillard P; Avril MF; Hercend T
    J Clin Invest; 1993 Mar; 91(3):1183-90. PubMed ID: 8450047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced growth of murine melanoma in ultraviolet-irradiated skin is associated with local inhibition of immune effector mechanisms.
    Donawho CK; Muller HK; Bucana CD; Kripke ML
    J Immunol; 1996 Jul; 157(2):781-6. PubMed ID: 8752929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous regression of metastases from malignant melanoma: a case report.
    Kalialis LV; Drzewiecki KT; Mohammadi M; Mehlsen AB; Klyver H
    Melanoma Res; 2008 Aug; 18(4):279-83. PubMed ID: 18626313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
    Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
    Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Humoral antitumor cytotoxins in patients with melanoma of the skin].
    Korosteleva TA; Veresova OV; Khachaturian LM
    Vopr Onkol; 1975; 21(5):61-3. PubMed ID: 1210146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma: criteria for histological diagnosis and its reporting.
    Metcalf JS
    Semin Oncol; 1996 Dec; 23(6):688-92. PubMed ID: 8970588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma.
    Prehn RT
    Cancer Res; 1996 Mar; 56(5):937-940. PubMed ID: 8640780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic profiles of individual-matched pairs of primary and melanoma metastases.
    Meije CB; Swart GW; Lepoole C; Das PK; Van den Oord JJ
    Hum Pathol; 2009 Oct; 40(10):1399-407. PubMed ID: 19386352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.